Test, FTA-ABS
FTA-ABS stands for fluorescent treponemal antibody absorbed, a blood serum screening test for syphilis designed to demonstrate the presence or absence of specific antibodies directed against the organism (Treponema pallidum) responsible for syphilis.
FTA-ABS detects the majority but not all cases of the disease. It is thus a way of screening for the disease.
A negative FTA-ABS test result is consistent with a person not having syphilis. However, a person may have a negative FTA-ABS test result while in the early (primary) and late (tertiary) stages of the disease. In the middle (secondary) stage of syphilis, the FTA-ABS test is most reliable and is reportedly positive in 100% of cases.
.
Read Also:
- Test, Gesell Developmental
The Neonatal Behavioral Assessment Scale (NBAS), better known as “the Brazelton” (because it was devised by the Harvard pediatrician T. Berry Brazelton); The Denver Developmental Screening Test (DDST) for children 0-6 years of age; The ELM (Early Language Milestone) scale for children 0-3 years of age; The CAT (Clinical Adaptive Test) and CLAMS (Clinical Linguistic […]
- Test, glucose tolerance
Malabsorption syndrome Insulinoma (an insulin-producing tumor) Addison disease (adrenocortical insufficiency) Hypopituitarism (underactivity of the pituitary gland) Hypothyroidism (underactivity of the thyroid gland) Since the dose of glucose is taken by mouth, the test is sometimes called an oral glucose tolerance test.
- Test, inkblot
A test used in clinical psychology and psychiatry involving inkblots. The inkblots are used to determine what a person perceives (reads into) in the enigmatic and highly ambiguous shapes. Ten standardized blots are shown one at a time to a subject and their responses are recorded. The Rorschach test became a common psychological test and […]
- Test, nerve conduction
Nerve conduction velocity test.
- Test, NSE
neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, endocrine tumors of the pancreas, and melanoma. Studies of NSE as a tumor marker have concentrated primarily on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease […]